Announced Tue, 7 Apr · 16:03 IST

Certificate pursuant of Regulations 74 (5)

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+2.9%1-day move

₹27.75

prior close

₹29.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+1.2-0.3-0.4-0.7+2.9+2.7-1.3+2.3+3.4-0.3-6.3-2.7-22.2-18.3

Up moveDown movePending

AI summary

Kabra Drugs Ltd has submitted a compliance certificate from its Registrar and Share Transfer Agent, Skyline Financial Services Pvt Ltd, under SEBI Regulation 74(5) for the quarter ended 31st March 2026. The certificate confirms that physical share certificates received for dematerialization were duly verified, mutilated, cancelled, and the depository was recorded as the registered owner within the required 15-day timeframe. The securities in question remain listed on the BSE. This is a routine quarterly compliance filing required from all listed companies whose shares are held in physical form.

Likely market impact

No material impact on shareholders or stock price. This is a standard procedural regulatory filing confirming routine dematerialization activity and has no bearing on the company's financial performance or operations.